Ben Tre Pharmaceutical JSC (HOSE:DBT)
10,000
-550 (-5.21%)
At close: Mar 9, 2026
HOSE:DBT Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Market Capitalization | 219,673 | 247,132 | 250,474 | 199,171 | 160,993 | 162,983 | Upgrade
|
| Market Cap Growth | -12.30% | -1.33% | 25.76% | 23.71% | -1.22% | -24.38% | Upgrade
|
| Enterprise Value | 725,031 | 805,383 | 604,689 | 553,386 | 394,589 | 347,380 | Upgrade
|
| Last Close Price | 10000.00 | 11250.00 | 11401.87 | 10001.64 | 8008.53 | 7447.13 | Upgrade
|
| PE Ratio | 15.65 | 17.61 | 18.57 | 15.36 | 7.53 | 8.07 | Upgrade
|
| PS Ratio | 0.26 | 0.29 | 0.29 | 0.25 | 0.20 | 0.20 | Upgrade
|
| PB Ratio | 0.76 | 0.85 | 0.88 | 0.80 | 0.68 | 0.68 | Upgrade
|
| P/TBV Ratio | 0.93 | 1.05 | 1.12 | 0.86 | 0.93 | 1.02 | Upgrade
|
| P/OCF Ratio | - | - | - | 550.74 | - | - | Upgrade
|
| EV/Sales Ratio | 0.84 | 0.94 | 0.70 | 0.68 | 0.49 | 0.43 | Upgrade
|
| EV/EBITDA Ratio | 11.46 | 12.73 | 9.23 | 7.28 | 9.19 | 8.62 | Upgrade
|
| EV/EBIT Ratio | 16.16 | 17.95 | 12.31 | 8.25 | 13.32 | 12.73 | Upgrade
|
| EV/FCF Ratio | -139.86 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 1.89 | 1.89 | 1.92 | 1.92 | 1.37 | 0.92 | Upgrade
|
| Debt / EBITDA Ratio | 8.67 | 8.67 | 8.32 | 6.27 | 7.60 | 5.49 | Upgrade
|
| Net Debt / Equity Ratio | 1.68 | 1.68 | 1.75 | 1.68 | 1.03 | 0.58 | Upgrade
|
| Net Debt / EBITDA Ratio | 7.70 | 7.70 | 7.60 | 5.48 | 5.69 | 3.43 | Upgrade
|
| Net Debt / FCF Ratio | -93.98 | -93.98 | -12.18 | -59.84 | -3.02 | -6.47 | Upgrade
|
| Asset Turnover | 0.87 | 0.87 | 0.94 | - | 1.22 | 1.31 | Upgrade
|
| Inventory Turnover | 1.17 | 1.17 | 1.26 | - | 2.71 | 3.55 | Upgrade
|
| Quick Ratio | 0.43 | 0.43 | 0.32 | 0.39 | 0.51 | 0.69 | Upgrade
|
| Current Ratio | 1.12 | 1.12 | 1.10 | 1.16 | 1.17 | 1.18 | Upgrade
|
| Return on Equity (ROE) | 4.95% | 4.95% | 4.61% | - | 10.11% | 8.75% | Upgrade
|
| Return on Assets (ROA) | 2.83% | 2.83% | 3.32% | - | 2.81% | 2.76% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.31% | 3.42% | 4.08% | 8.86% | 5.57% | 5.92% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.50% | 14.50% | 15.40% | 25.90% | 11.90% | 11.40% | Upgrade
|
| Earnings Yield | 6.39% | 5.68% | 5.82% | 8.13% | 13.29% | 12.39% | Upgrade
|
| FCF Yield | -2.36% | -2.10% | -16.32% | -3.49% | -50.28% | -13.09% | Upgrade
|
| Payout Ratio | - | - | - | - | 63.23% | 90.84% | Upgrade
|
| Buyback Yield / Dilution | -17.56% | -17.56% | -9.97% | - | - | - | Upgrade
|
| Total Shareholder Return | -17.56% | -17.56% | -9.97% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.